# Lotus Pharmaceuticals, Inc. (LTUS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LTUS)

## Price

| Indicator | Value |
| --- | --- |
| Market Cap | $ 104.3K |

## Valuation

| Indicator | Value |
| --- | --- |
| P/E10 | 0.01 |
| P/FCF10 | 0.61 |

Widest P/E window this company has the history to fill: 10 years. Shorter windows are still computed; longer ones are left empty rather than padded.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.04 |
| Liabilities / Eq | -1.04 |
| Current Ratio | 0.03 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.01 |
| Gross Debt / FCF | 0.72 |

## Other views

- [Charts](https://sponda.capital/en/LTUS/charts.md)
- [Fundamentals](https://sponda.capital/en/LTUS/fundamentals.md)
- [Compare](https://sponda.capital/en/LTUS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.